Dr Andrew Schmidt is a medical oncologist experienced in treating a broad range of cancer types. His personable and thorough approach to patient care is complemented by significant recent international experience conducting research and cancer clinical trials.

Andrew is skilled at tailoring your oncology treatment plan to align with personal hopes and expectations. Recent experience at Harvard Cancer Centre (Dana-Farber) with world-leading clinicians and researchers allows his clinical care to be supported by an in-depth knowledge of contemporary personalised medicine and immunotherapy. Ongoing research collaboration with colleagues in the United States continually delivers timely access to new developments in cancer medicine.

His passion for improving the clinical care of cancer patients began while working as an Oncology Pharmacist. A Bachelor of Medicine, Bachelor of Surgery was awarded from the University of Queensland in 2010, followed by postgraduate training in Medical Oncology across Queensland. He was awarded a Fellowship with the Royal Australasian College of Physicians in Medical Oncology in 2017. A special interest in clinical trials was then developed while working at the Olivia Newton-John Cancer Wellness and Research Centre in Melbourne (2018), focusing on urologic, head and neck, and brain cancers.

His career continued at the Dana-Farber Cancer Institute in Boston, Massachusetts, including extensive work researching urologic tumours and Coronavirus disease 2019. His research portfolio includes numerous peer-reviewed publications in leading scientific and clinical journals.